ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 146 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $70,000 | +11.1% | 6,144 | +101.6% | 0.00% | – |
| Q1 2017 | $63,000 | +200.0% | 3,048 | +204.8% | 0.00% | – |
| Q4 2016 | $21,000 | -44.7% | 1,000 | -13.0% | 0.00% | – |
| Q3 2016 | $38,000 | +850.0% | 1,150 | +666.7% | 0.00% | – |
| Q2 2016 | $4,000 | 0.0% | 150 | 0.0% | 0.00% | – |
| Q1 2016 | $4,000 | -80.0% | 150 | -74.9% | 0.00% | – |
| Q3 2015 | $20,000 | +17.6% | 598 | 0.0% | 0.00% | – |
| Q1 2015 | $17,000 | 0.0% | 598 | 0.0% | 0.00% | – |
| Q4 2014 | $17,000 | +112.5% | 598 | 0.0% | 0.00% | – |
| Q3 2014 | $8,000 | – | 598 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,130 | $37,365,000 | 8.14% |
| Foresite Capital Management II, LLC | 1,686,220 | $21,415,000 | 7.12% |
| Foresite Capital Management IV, LLC | 830,919 | $10,553,000 | 4.38% |
| SENZAR ASSET MANAGEMENT, LLC | 822,890 | $10,451,000 | 3.30% |
| Redmile Group, LLC | 6,505,766 | $82,623,000 | 3.19% |
| DAFNA Capital Management LLC | 396,013 | $5,029,000 | 2.45% |
| SECTORAL ASSET MANAGEMENT INC | 863,600 | $10,968,000 | 1.20% |
| Palo Alto Investors LP | 1,849,832 | $23,493,000 | 1.00% |
| Bellevue Group AG | 700,464 | $8,896,000 | 0.88% |
| Rock Springs Capital Management LP | 1,529,800 | $19,428,000 | 0.83% |